Qube Research & Technologies LTD Ampio Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.08 - $21.0 $1,684 - $442,155	-21,055 Reduced 12.26%	150,737 $9,000
Q2 2022 Aug 15, 2022	BUY	$0.16 - $0.47 $27,486 - $80,742	171,792 New	171,792 $29,000
Q2 2021 Aug 13, 2021	SELL	$1.56 - $1.98 $52,203 - $66,258	-33,464 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$1.36 - $2.49 $58,772 - $107,605	-43,215 Reduced 56.36%	33,464 $57,000
Q4 2020 Feb 16, 2021	BUY	$0.75 - $2.76 $57,509 - $211,634	76,679 New	76,679 $122,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.